Cinacalcet

TENALCET®

Cinacalcet 30mg.  Coated tablets.
Cinacalcet 60mg.  Coated tablets.


Therapeutical classification:

Calcic Homeostasis.


How supplied:

TENALCET® / CINACALCET 30 mg: Packages containing 30 coated tablets.
TENALCET® / CINACALCET 60 mg: Packages containing 30 coated tablets.


Indications:

Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis.
Hypercalcemia in adult patients with Parathyroid carcinoma.
Hypercalcemia in adult patients with primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but it is not clinically adequate or contraindicated.


Dose and administration:

Secondary  Hyperparathyroidism  
Adults and people > 65 years
The recommended  starting dose is 30 mg once daily. The dose of Tenalcet® must be titrated each 2 to 4 weeks to a maximal dose of 180 mg once daily.

Parathyroid carcinoma and Primary Hyperparathyroidism
Adults and people > 65 years
The recommended  starting dose is 30 mg  twice daily. The dose of  Tenalcet® must be Titrated every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg three or four times daily as necessary to normalize serum calcium levels.

For further information, please, read the full prospect.


Storage:

Store at room temperature under 25ºC, in its original package.

 

Encarnación Ezcurra 365 Piso 3, C1107CLA, Buenos Aires, Argentina - Phone/Fax: 54 11 5787 2222